Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration
Creators
- 1. Department of Neurology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, No. 107, West Yanjiang Road, Guangzhou 510120, People's Republic of China (China)
- 2. School of Chemistry and Chemical Engineering, Sun Yat-Sen University, Guangzhou 510275, People's Republic of China (China)
- 3. Department of Neurology, The First Affiliated Hospital of Jinan University, No. 613, West Huangpu Road, Guangzhou 510630, People's Republic of China (China)
Description
Highlights: ► Nogo receptor can inhibit growth of injured axons, thus affecting neural regeneration. ► The delivery of siRNA is crucial to inhibit NgR expression in NSCs. ► Non-viral vector PEG-PEI condensed siRNA targeting NgR into nanoscale particles. ► PEG-PEI/siRNA at N/P = 15 displayed high transfection efficiency and low cytotoxicity. ► PEG-PEI has great potential in carrying siRNA to diminish the gene expression in NSCs. -- Abstract: The therapeutic applications of neural stem cells (NSCs) have potential to promote recovery in many obstinate diseases in central nervous system. Regulation of certain gene expressions using siRNA may have significant influence on the fate of NSC. To achieve the optimum gene silencing effect of siRNA, non-viral vector polyethylene glycol-polyethyleneimine (PEG-PEI) was investigated in the delivery of siRNA to NSCs. The characteristics of PEG-PEI/siRNA polyplexes were detected by scanning electron microscopy (SEM). The effects of nanoparticles on cell viability were measured via CCK-8 assay. In addition, the transfection efficiency was evaluated by fluorescence microscope and flow cytometry, and real-time PCR and Western Blot were employed to detect the gene inhibition effect of siRNA delivered by PEG-PEI. The SEM micrographs showed that PEG-PEI could condense siRNA to form diffuse and spherical nanoparticles. The cytotoxicity of PEG-PEI/siRNA nanocomplexes (N/P = 15) was significantly lower when compared with that of Lipofectamine 2000/siRNA (P < 0.05). Moreover, the highest transfection efficiency of PEG-PEI/siRNA nanoparticles was obtained at an N/P ratio of 15, which was better than that achieved in the transfection using Lipofectamine 2000 (P < 0.05). Finally, the gene knockdown effect of PEG-PEI/siRNA nanoparticles was verified at the levels of mRNA and protein. These results suggest that PEG-PEI may potentially be used as a siRNA delivery vector for neural regeneration therapy.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2012.03.155Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2012.03.155;
- PII
- S0006-291X(12)00729-2;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 421
- Journal Issue
- 4
- Journal Page Range
- p. 690-695
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45028765
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- CENTRAL NERVOUS SYSTEM; DISEASES; FLUORESCENCE; GENE THERAPY; GENES; MESSENGER-RNA; NANOSTRUCTURES; NERVE CELLS; PHOSPHATES; POLYETHYLENE GLYCOLS; POLYMERASE CHAIN REACTION; RECEPTORS; STEM CELLS; TOXICITY
- Descriptors DEC
- ALCOHOLS; ANIMAL CELLS; EMISSION; GENE AMPLIFICATION; GLYCOLS; HYDROXY COMPOUNDS; LUMINESCENCE; MEDICINE; MEMBRANE PROTEINS; NERVOUS SYSTEM; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANIC POLYMERS; OXYGEN COMPOUNDS; PHOSPHORUS COMPOUNDS; PHOTON EMISSION; POLYMERS; PROTEINS; RNA; SOMATIC CELLS; THERAPY
Optional Information
- Copyright
- Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.